In 2024-2025, Novo Nordisk offered rebates of 40% to 60% to secure exclusive or preferred placement for Wegovy over Zepbound
Bernie Sanders excoriated the CEO of Novo Nordisk (the manufacturer of Ozempic and Wegovy), Lars Fruergaard Jrgensen, because people in the U.S
The choice depends on the compounds intended use, absorption goals, and provider direction
People with type 2 diabetes who take Wegovy may have an increased risk of plaque buildup in their arteries, leading to dangerous blood clots, and should be carefully monitored
This injectable solution is crucial for healthcare as it quickly helps with vitamin B deficiencies that some people may experience difficulty absorbing through supplements
Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial